Revenue and Financial Management
Revenue for Q1 2025 was $2.1 million with a strong average selling price. The company raised $6 million through a registered direct offering, extending the cash runway to the end of 2026.
Diversified Growth Strategy
Hyperfine is transitioning from a reliance on U.S. hospital deals to a diversified portfolio including hospitals, office settings, and international markets. The launch of the office business and improved technology are expected to drive growth in the second-half of 2025.
International Expansion
Strong interest and demand are seen across Europe, the Middle East, and Asia, with anticipated regulatory approval and market entrance in India in the second-half of the year.
Technological Advancements
The company is improving the image quality of their AI-powered portable MRI, with expected clearance for next-generation software and technology releases later in the year.